|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8640 EUR | +0.70% |
|
-3.46% | -43.75% |
| 06-18 | AB Science Secures US Patent for Prostate Cancer Therapy | MT |
| 06-18 | AB Science Secures New U.S. Patent for Masitinib |  |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | - | - | - | - | - | 74.76M | |
| 55.97x | 6.38x | -0.81x | 5.19x | 21.24x | 30.41x | 2.67% | 310B | |
| 24.83x | 2.09x | -18.59x | 3.4x | 12.06x | 19.79x | 1.58% | 72.76B | |
| 10.79x | 11.42x | 0.07x | 5.53x | 8.52x | 9.36x | - | 8.62B | |
| 16.63x | 1.43x | 0.82x | 2.1x | 7.22x | 8.62x | 2.69% | 8.29B | |
| 23.63x | 6.29x | 2.37x | 6.74x | 19.15x | 20.02x | -.--% | 4.5B | |
| 33.07x | - | 0.21x | 6.27x | 17.93x | 29.05x | - | 3.83B | |
| 39.59x | 2.36x | -1.29x | 2.24x | 27.35x | 41.13x | 0.78% | 3.45B | |
| 103.27x | - | -0.63x | - | - | - | -.--% | 2.6B | |
| 12.9x | 0.86x | 0.91x | 1.17x | 29.47x | -80.28x | 3.97% | 1.03B | |
| -7.4x | 12.37x | 0.45x | 204.46x | -6.58x | -5.16x | -.--% | 950M | |
| 43.4x | 6.8x | -1.13x | 14.42x | 30.29x | 35.63x | - | 906M | |
| 48.14x | - | -0.09x | - | - | - | - | 954M | |
| Average | 33.74x | 5.56x | -1.47x | 25.15x | 16.66x | 10.86x | 1.46% | 32.14B | |
| Weighted average by Cap. | 48.14x | 5.59x | -3.81x | 5.29x | 19.06x | 27.29x | 2.41% |
- Stock Market
- Stocks
- AB Stock
- Sector AB Science
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
